CM Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Sell
2,558
-366
-13% -$371K 0.5% 26
2025
Q4
$3.14M Buy
2,924
+1,224
+72% +$1.17M 0.71% 17
2025
Q3
$1.3M Hold
1,700
0.34% 27
2025
Q2
$1.33M Hold
1,700
0.39% 25
2025
Q1
$1.4M Hold
1,700
0.45% 23
2024
Q4
$1.31M Hold
1,700
0.43% 22
2024
Q3
$1.51M Buy
+1,700
New +$1.53M 0.49% 21
2024
Q1
Sell
-1,200
Closed -$700K 189
2023
Q4
$700K Hold
1,200
0.3% 27
2023
Q3
$734K Sell
1,200
-711
-37% -$366K 0.28% 27
2023
Q2
$876K Buy
+1,911
New +$801K 0.29% 36
2023
Q1
Sell
-1,200
Closed -$439K 429
2022
Q4
$439K Hold
1,200
0.22% 44
2022
Q3
$388M Hold
1,200
0.22% 48
2022
Q2
$389K Buy
+1,200
New +$360K 0.24% 50

Other funds holding LLY

CM Wealth Advisors's LLY Position: Q1 2026 in Review

CM Wealth Advisors reduced its Eli Lilly (LLY) stake by 13% in Q1 2026, selling an estimated $371K and leaving 2,558 shares worth $2.35M. The position accounts for 0.5% of the portfolio, ranked #26.

CM Wealth Advisors first reported a position in LLY in Q2 2022 and has held it in 13 quarters since. The position peaked at $388M in Q3 2022. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • CM Wealth Advisors held 2,558 shares of Eli Lilly worth $2.35M as of Q1 2026.
  • CM Wealth Advisors sold 366 Eli Lilly shares in Q1 2026, an estimated $371K.
  • Eli Lilly made up 0.5% of CM Wealth Advisors's portfolio in Q1 2026, its #26 holding.
  • CM Wealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 13 quarters since.
  • CM Wealth Advisors's Eli Lilly position peaked at $388M in Q3 2022.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CM Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.